A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

Biohaven's pipeline includes Troriluzole for SCA, BHV-2100 for migraines, and Taldefgrobep Alfa for SMA. See why BHVN stock ...

Despite Pfizer's (NYSE: PFE) recent struggles with falling earnings and a bid by an activist investor to unseat its ...

Few companies garner as much reliable attention as Novo Nordisk ( NVO) does these days. With a bull market coinciding with a ...

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, ...

The rising popularity of appetite suppressant ‘obesity drugs’ is causing people to eat less when dining out. Is this a threat ...

Adcendo has tapped into the strong investor appetite for companies developing antibody-drug conjugates for cancer with an ...

Fatty liver disease is a growing health concern that often develops silently, showing no clear symptoms in its early stages.

Another day, another headline suggesting the new breed of diabetes and weight loss drugs offer hope for another chronic ...